BackTable ENT & AllergyShareCase · 28 Oct 2025HNC: T2N3 Primary Low Volume Head & Neck Squamous Cell Carcinomawith Dr. Dylan Roden, Dr. Ravindra Uppaluri, Dr. Adam LuginbuhlChemotherapyHead and Neck Cancer (HNC)ImmunotherapyNeoadjuvant ImmunotherapyOtolaryngologyPathologyRadiation TherapySurgical OncologyYou may also likeLoadingLoadingLoadingLoading
